Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients
Abstract Background This study aims to find the chemosensitive dysfunction incidence in COVID-19-positive patients and its recovery. We collected the data from sixty-five patients, all COVID-19 positive, quarantined in-hospital between 5 April 2020 and 17 May 2020, by a questionnaire distributed in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2020-10-01
|
| Series: | The Egyptian Journal of Otolaryngology |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s43163-020-00050-0 |
| _version_ | 1827279988931428352 |
|---|---|
| author | Haider Majid Haider Al-Zaidi Hani Musa Badr |
| author_facet | Haider Majid Haider Al-Zaidi Hani Musa Badr |
| author_sort | Haider Majid Haider Al-Zaidi |
| collection | DOAJ |
| description | Abstract Background This study aims to find the chemosensitive dysfunction incidence in COVID-19-positive patients and its recovery. We collected the data from sixty-five patients, all COVID-19 positive, quarantined in-hospital between 5 April 2020 and 17 May 2020, by a questionnaire distributed in the quarantine ward. Results Smell dysfunction appeared in 89.23% with or without other symptoms of COVID-19. 39.66% of them recovered the sense of smell. Taste dysfunction found in 83.08% patients with other COVID-19 symptoms. Only 29.63% of them recovered. The recovery took 1–3 weeks, and most cases recovered within 1 week or less. 18.46% and 15.38% had smell and taste dysfunction, respectively, as the only symptom before COVID-19 confirmation. Most of the chemosensitive dysfunction affected the 4th decade of age in this study. Conclusion Chemosensitive dysfunction is associated with coronavirus disease and may be the only symptom that presents the disease. This makes the ENT doctors the first line of contact with the coronavirus. Further objective studies are required to cover chemosensitive dysfunctions, as the recognition of this dysfunction may help the diagnosis of COVID-19, and prevent the spread of this disease. |
| first_indexed | 2024-04-24T08:29:16Z |
| format | Article |
| id | doaj.art-96296ed107f5469980751d19322cb8e1 |
| institution | Directory Open Access Journal |
| issn | 1012-5574 2090-8539 |
| language | English |
| last_indexed | 2024-04-24T08:29:16Z |
| publishDate | 2020-10-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | The Egyptian Journal of Otolaryngology |
| spelling | doaj.art-96296ed107f5469980751d19322cb8e12024-04-16T20:43:30ZengSpringerOpenThe Egyptian Journal of Otolaryngology1012-55742090-85392020-10-013611610.1186/s43163-020-00050-0Incidence and recovery of smell and taste dysfunction in COVID-19 positive patientsHaider Majid Haider Al-Zaidi0Hani Musa Badr1College of Medicine, Ibn Sina University of Medical and Pharmaceutical SciencesGazi Alhariri HospitalAbstract Background This study aims to find the chemosensitive dysfunction incidence in COVID-19-positive patients and its recovery. We collected the data from sixty-five patients, all COVID-19 positive, quarantined in-hospital between 5 April 2020 and 17 May 2020, by a questionnaire distributed in the quarantine ward. Results Smell dysfunction appeared in 89.23% with or without other symptoms of COVID-19. 39.66% of them recovered the sense of smell. Taste dysfunction found in 83.08% patients with other COVID-19 symptoms. Only 29.63% of them recovered. The recovery took 1–3 weeks, and most cases recovered within 1 week or less. 18.46% and 15.38% had smell and taste dysfunction, respectively, as the only symptom before COVID-19 confirmation. Most of the chemosensitive dysfunction affected the 4th decade of age in this study. Conclusion Chemosensitive dysfunction is associated with coronavirus disease and may be the only symptom that presents the disease. This makes the ENT doctors the first line of contact with the coronavirus. Further objective studies are required to cover chemosensitive dysfunctions, as the recognition of this dysfunction may help the diagnosis of COVID-19, and prevent the spread of this disease.http://link.springer.com/article/10.1186/s43163-020-00050-0Chemosensitive dysfunctionsAnosmiaTaste lossCOVID-19 |
| spellingShingle | Haider Majid Haider Al-Zaidi Hani Musa Badr Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients The Egyptian Journal of Otolaryngology Chemosensitive dysfunctions Anosmia Taste loss COVID-19 |
| title | Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients |
| title_full | Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients |
| title_fullStr | Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients |
| title_full_unstemmed | Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients |
| title_short | Incidence and recovery of smell and taste dysfunction in COVID-19 positive patients |
| title_sort | incidence and recovery of smell and taste dysfunction in covid 19 positive patients |
| topic | Chemosensitive dysfunctions Anosmia Taste loss COVID-19 |
| url | http://link.springer.com/article/10.1186/s43163-020-00050-0 |
| work_keys_str_mv | AT haidermajidhaideralzaidi incidenceandrecoveryofsmellandtastedysfunctionincovid19positivepatients AT hanimusabadr incidenceandrecoveryofsmellandtastedysfunctionincovid19positivepatients |